CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Conditions:   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Invasive Breast Carcinoma;   Prognostic Stage II Breast Cancer AJCC v8;   Prognost ic Stage IIA Breast Cancer AJCC v8;   Prognostic Stage IIB Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8 Interventions:   Drug: Docetaxel;   Procedure: Lumpectomy;   Procedure: Mastectomy;   Drug: Nab-paclitaxel;   Drug: Paclitaxel;   Biological: Pertuzumab;   Radiation: Radiation Therapy;   Biological: Trastuzumab;   Biological: Trastuzumab Emtansine Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials